BWM
AMED

Birchcreek Wealth Management’s Amedisys AMED Stock Holding History

Birchcreek Wealth Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-230
Closed -$67K – 118
2020
Q4 		$67K Buy
+230
New +$59K 0.07% 182

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Birchcreek Wealth Management's AMED Position: Q1 2021 in Review

Birchcreek Wealth Management sold out of Amedisys (AMED) in Q1 2021, closing a stake of 230 shares — an estimated $67K sold.

Birchcreek Wealth Management first reported a position in AMED in Q4 2020 and held it in 1 quarter. The position peaked at $67K in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Birchcreek Wealth Management reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Birchcreek Wealth Management sold 230 Amedisys shares in Q1 2021, an estimated $67K.
  • Birchcreek Wealth Management first reported a position in Amedisys in Q4 2020 and held it in 1 quarter.
  • Birchcreek Wealth Management's Amedisys position peaked at $67K in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Birchcreek Wealth Management's 13F filing for Q1 2021, filed 17 May 2021.